Corrected: Immunovia and University College of London sign agreement to expand validation studies of IMMray™ PanCan-d for early signs and symptoms
LUND, SWEDEN - Immunovia today announced that Prof. Stephen Pereira and his team at the institute for Liver and Digestive Health, University College London (UCL) will expand the prospective collection of blood samples funded by Immunovia and that started with the PanSYM-1 pilot study.The pilot PanSYM-1 study at UCL that started in 2017 (PR from November 2nd, 2017 ) is scheduled for readout in 2019 and, following today’s news, will now support the continuation of PanSYM-1 as a prospective validation study. The continued PanSYM-1 study